Archna Eniasivam

Archna Eniasivam practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Archna Eniasivam's NPI, 1376834481, was assigned on April 22, 2011. Archna Eniasivam holds California license A136397.

Archna Eniasivam's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Archna Eniasivam's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Archna Eniasivam to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Archna Eniasivam practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Archna Eniasivam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Archna Eniasivam is licensed in California.

CMS data shows 135 Medicare services from Archna Eniasivam across 3 procedure codes in 2024, for 69 Medicare patients. Medicare paid $11,644 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Archna Eniasivam in 2024. The largest group is 75 to 84, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Archna Eniasivam's median patient age at 63, with 49% women.

In 2024, Archna Eniasivam wrote 37 Medicare Part D claims for 19 patients. 73% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $3,096 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Archna Eniasivam for performance year 2024, reported as part of a group. Archna Eniasivam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.